Publication Name	World Journal of Gastroenterology
Manuscript ID	51939
Country	United States

Received	2019-10-11 19:54
Peer-Review Started	2019-10-11 19:54
To Make the First Decision
Return for Revision	2019-12-05 22:21
Revised	2020-01-02 13:10
Second Decision	2020-01-09 11:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-01-11 14:17
Articles in Press	2020-01-11 14:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-01-17 08:03
Publish the Manuscript Online	2020-01-18 06:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Opinion Review
Article Title	Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
Manuscript Source	Invited Manuscript
All Author List	Jordan M Cloyd, Allan Tsung, John Hays, Celia E Wills and John FP Bridges
Funding Agency and Grant Number
Corresponding Author	Jordan M Cloyd, MD, Assistant Professor, Department of Surgery, The Ohio State University, 410 W 10th Ave, N-907, Columbus, OH 43210, United States. jordan.cloyd@osumc.edu
Key Words	Preoperative therapy; Pancreatic ductal adenocarcinoma; Quality of life; Shared decision making; Patient preferences;
Core Tip	Neoadjuvant therapy is increasingly being recommended to patients with pancreatic ductal adenocarcinoma, however, patient-centered research on its use is lacking. In this review, we highlight opportunities to focus research efforts in the domains of patient preferences, patient-reported outcomes, patient experience, and survivorship. Novel research in these areas may identify relevant barriers and facilitators to the use of neoadjuvant therapy thereby increasing its utilization, improving shared-decision making for patients and providers, and optimizing the experience of those undergoing neoadjuvant therapy.
Publish Date	2020-01-18 06:08
Citation	Cloyd JM, Tsung A, Hays J, Wills CE, Bridges JFP. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. World J Gastroenterol 2020; 26(4): 375-382
URL	https://www.wjgnet.com/1007-9327/full/v26/i4/375.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i4.375

Full Article (PDF)	WJG-26-375.pdf
Full Article (Word)	WJG-26-375.docx
Manuscript File	51939-Review.docx
Answering Reviewers	51939-Answering reviewers.pdf
Audio Core Tip	51939-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	51939-Conflict-of-interest statement.pdf
Copyright License Agreement	51939-Copyright license agreement.pdf
Peer-review Report	51939-Peer-review(s).pdf
Scientific Misconduct Check	51939-Scientific misconduct check.pdf
Scientific Editor Work List	51939-Scientific editor work list.pdf